Page last updated: 2024-10-22

amifostine anhydrous and Experimental Leukemia

amifostine anhydrous has been researched along with Experimental Leukemia in 3 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valeriote, F1
Tolen, S1
Antoku, S1
DeNeve, WJ1
Everett, CK1
Suminski, JE1
Valeriote, FA1

Other Studies

3 other studies available for amifostine anhydrous and Experimental Leukemia

ArticleYear
Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Amifostine; Animals; Cell Survival; Drug Interactions; Drug Synergism; Hematopoietic Stem Cells; Leu

1982
Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
    International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:10

    Topics: Amifostine; Animals; Cells, Cultured; Cobalt Radioisotopes; Cysteamine; Dose-Response Relationship,

1983
Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    Cancer research, 1988, Nov-01, Volume: 48, Issue:21

    Topics: Amifostine; Animals; Bone Marrow; DNA; DNA Damage; Female; Leukemia, Experimental; Male; Mechloretha

1988